Insys Therapeutics, Inc. (INSYQ) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
10220 SOUTH 51ST STREET PHOENIX, AZ 85044 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2019 MRQ | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 104,100 | 117,188 | 182,880 | 159,091 | 82,863 | 45,382 | |||
| Cash and cash equivalents | 31,552 | 31,999 | 104,642 | 79,515 | 58,106 | 45,382 | |||
| Short-term investments | 64,126 | 85,189 | 78,238 | 79,576 | 24,757 | ||||
| Other undisclosed cash, cash equivalents, and short-term investments | 8,422 | ||||||||
| Receivables | 12,610 | 21,513 | 20,654 | 48,459 | 26,544 | 16,313 | |||
| Inventory, net of allowances, customer advances and progress billings | 8,608 | 17,408 | 21,743 | 41,715 | 34,781 | 14,528 | |||
| Inventory | 8,608 | 17,408 | 21,743 | 41,715 | 34,781 | 14,528 | |||
| Deferred tax assets | 4,611 | 3,800 | |||||||
| Other undisclosed current assets | 974 | 19,833 | 5,695 | 3,973 | 2,243 | 2,127 | |||
| Total current assets: | 126,292 | 175,942 | 230,972 | 253,238 | 151,042 | 82,150 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | (3,318) | ||||||||
| Property, plant and equipment | 52,086 | 55,174 | 43,172 | 38,382 | 29,872 | 10,127 | |||
| Long-term investments and receivables | 8,446 | 46,733 | 53,796 | 43,219 | 23,262 | ||||
| Long-term investments | 8,446 | 46,733 | 53,796 | 43,219 | 23,262 | ||||
| Other noncurrent assets | 5,703 | 1,231 | 4,953 | 26 | 3,343 | 43 | |||
| Deferred tax assets, net | 23,243 | 7,602 | 8,238 | ||||||
| Other undisclosed noncurrent assets | 16,331 | 3,318 | |||||||
| Total noncurrent assets: | 66,235 | 103,138 | 125,164 | 97,958 | 64,079 | 18,408 | |||
| TOTAL ASSETS: | 192,527 | 279,080 | 356,136 | 351,196 | 215,121 | 100,558 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 50,859 | 30,438 | 27,359 | 36,354 | 27,454 | 16,557 | |||
| Employee-related liabilities | 6,437 | 8,808 | 8,833 | 10,225 | 6,926 | 3,568 | |||
| Other undisclosed accounts payable and accrued liabilities | 44,422 | 21,630 | 18,526 | 26,129 | 20,528 | 12,989 | |||
| Estimated litigation liability | 41,402 | 150,534 | 13,467 | 9,567 | |||||
| Customer refund liability | 8,162 | 16,290 | 28,955 | 32,713 | 11,296 | ||||
| Deferred revenue and credits | ✕ | ✕ | 1,109 | ||||||
| Other undisclosed current liabilities | 6,437 | 8,808 | 8,833 | 10,225 | 6,926 | 4,524 | |||
| Total current liabilities: | 106,860 | 207,179 | 78,614 | 88,859 | 45,676 | 21,081 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 128,767 | 8,619 | 7,933 | 8,635 | 3,778 | ||||
| Liability for uncertainty in income taxes | 3,767 | 8,619 | 7,933 | 8,635 | 3,778 | ||||
| Estimated litigation liability | 125,000 | ||||||||
| Total noncurrent liabilities: | 128,767 | 8,619 | 7,933 | 8,635 | 3,778 | ||||
| Total liabilities: | 235,627 | 215,798 | 86,547 | 97,494 | 49,454 | 21,081 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (43,100) | 63,282 | 269,589 | 253,702 | 165,667 | 79,477 | |||
| Common stock | 744 | 736 | 719 | 719 | 354 | 5 | |||
| Treasury stock, value | (32,558) | (32,558) | (32,558) | ||||||
| Additional paid in capital | 292,508 | 278,356 | 256,529 | 245,736 | 216,414 | 168,526 | |||
| Accumulated other comprehensive loss | (269) | (438) | (302) | (152) | (24) | ||||
| Retained earnings (accumulated deficit) | (336,083) | (215,351) | 12,664 | 7,420 | (51,056) | (89,033) | |||
| Stockholders' equity note, subscriptions receivable | (21) | ✕ | ✕ | ✕ | |||||
| Other undisclosed equity, attributable to parent | 32,558 | 32,558 | 32,537 | (21) | (21) | (21) | |||
| Total equity: | (43,100) | 63,282 | 269,589 | 253,702 | 165,667 | 79,477 | |||
| TOTAL LIABILITIES AND EQUITY: | 192,527 | 279,080 | 356,136 | 351,196 | 215,121 | 100,558 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 82,080 | 140,693 | 242,275 | 330,797 | 222,125 | 99,289 | ||
| Revenue, net | ✕ | ✕ | 140,693 | 242,275 | 330,797 | 222,125 | 99,289 | |
| Cost of revenue | (10,803) | (20,643) | (25,393) | (28,854) | (22,578) | (12,665) | ||
| Cost of goods and services sold | (3,095) | (6,186) | ||||||
| Gross profit: | 71,277 | 120,050 | 216,882 | 301,943 | 199,547 | 86,624 | ||
| Operating expenses | (199,000) | (339,081) | (209,556) | (209,513) | (135,524) | (54,065) | ||
| Operating income (loss): | (127,723) | (219,031) | 7,326 | 92,430 | 64,023 | 32,559 | ||
| Nonoperating income (expense) | 1,316 | 1,836 | 1,098 | 538 | 153 | (982) | ||
| Investment income, nonoperating | 1,984 | 1,881 | 1,039 | 502 | 151 | |||
| Other nonoperating income (expense) | (668) | (45) | 59 | 36 | 2 | (54) | ||
| Interest and debt expense | (900) | |||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 900 | |||||||
| Income (loss) from continuing operations before income taxes: | (126,407) | (217,195) | 8,424 | 92,968 | 64,176 | 31,577 | ||
| Income tax expense (benefit) | 1,900 | (10,820) | (834) | (34,492) | (26,199) | 8,800 | ||
| Income (loss) from continuing operations: | (124,507) | (228,015) | 7,590 | 58,476 | 37,977 | 40,377 | ||
| Income (loss) before gain (loss) on sale of properties: | (124,507) | (228,015) | 7,590 | 58,476 | 37,977 | 40,377 | ||
| Net income (loss) available to common stockholders, diluted: | (124,507) | (228,015) | 7,590 | 58,476 | 37,977 | 40,377 | ||
Comprehensive Income ($ in thousands)
| 3/31/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (124,507) | (228,015) | 7,590 | 58,476 | 37,977 | 40,377 | ||
| Comprehensive income (loss): | (124,507) | (228,015) | 7,590 | 58,476 | 37,977 | 40,377 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 169 | (136) | (150) | (128) | (24) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (124,338) | (228,151) | 7,440 | 58,348 | 37,953 | 40,377 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.